Artiva Biotherapeutics, Inc. ARTV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.8M+27.7% | $69.54M+38.2% | $65.86M+36.7% | $61.75M+29.4% | $56.23M+20.6% | ||
| $20.27M+8.2% | $20.27M+17.8% | $20.28M+31.5% | $19.83M+48.1% | $18.74M+37.8% | ||
| $92.07M+22.8% | $89.81M+33.0% | $86.15M+35.5% | $81.58M+33.5% | $74.96M+24.5% | ||
| -$92.07M-22.8% | -$89.81M-33.5% | -$86.15M-41.3% | -$81.58M-156% | -$74.96M-173% | ||
| $5M+54.2% | $5.95M+211% | $6.96M+3,306% | $6.45M+1,154% | $3.24M+105% | ||
| -$87.07M-21.4% | -$83.87M-28.3% | -$79.19M-29.2% | -$75.13M-131% | -$71.72M-176% | ||
| -$3.54— | -$3.42— | —— | —— | —— | ||
| -$89.43M-23.4% | -$87.21M-34.5% | -$83.6M-42.7% | -$79.07M-168% | -$72.49M— | ||
| -$92.07M-22.8% | -$89.81M-33.5% | -$86.15M-41.3% | -$81.58M-156% | -$74.96M-173% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Artiva Biotherapeutics, Inc. profitable?
- Artiva Biotherapeutics, Inc. is not currently profitable: it reported a net loss of $87.1M over the trailing twelve months, a -79.3% net margin.
- What is Artiva Biotherapeutics, Inc.'s earnings per share?
- Artiva Biotherapeutics, Inc.'s diluted EPS over the trailing twelve months is $-3.54.
- Where does Artiva Biotherapeutics, Inc.'s income statement data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.